| Product Code: ETC5298900 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Parenteral Drugs Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Parenteral Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Parenteral Drugs Market - Industry Life Cycle |
3.4 Ireland Parenteral Drugs Market - Porter's Five Forces |
3.5 Ireland Parenteral Drugs Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Ireland Parenteral Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Parenteral Drugs Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.8 Ireland Parenteral Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Ireland Parenteral Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Parenteral Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring parenteral drug administration |
4.2.2 Growing aging population in Ireland leading to higher demand for parenteral drugs |
4.2.3 Technological advancements in drug delivery systems improving efficiency and effectiveness of parenteral drugs |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for parenteral drugs |
4.3.2 High cost associated with parenteral drug development and manufacturing |
4.3.3 Limited awareness and education among healthcare professionals about the benefits of parenteral drugs |
5 Ireland Parenteral Drugs Market Trends |
6 Ireland Parenteral Drugs Market Segmentations |
6.1 Ireland Parenteral Drugs Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Parenteral Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F |
6.1.3 Ireland Parenteral Drugs Market Revenues & Volume, By Immunoglobulin, 2021-2031F |
6.1.4 Ireland Parenteral Drugs Market Revenues & Volume, By Cytokines, 2021-2031F |
6.1.5 Ireland Parenteral Drugs Market Revenues & Volume, By Insulin, 2021-2031F |
6.1.6 Ireland Parenteral Drugs Market Revenues & Volume, By Peptide Hormones, 2021-2031F |
6.1.7 Ireland Parenteral Drugs Market Revenues & Volume, By Blood Factors, 2021-2031F |
6.1.9 Ireland Parenteral Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Ireland Parenteral Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Ireland Parenteral Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Parenteral Drugs Market Revenues & Volume, By Oncology, 2021-2031F |
6.2.3 Ireland Parenteral Drugs Market Revenues & Volume, By Infectious Diseases, 2021-2031F |
6.2.4 Ireland Parenteral Drugs Market Revenues & Volume, By Diabetes, 2021-2031F |
6.2.5 Ireland Parenteral Drugs Market Revenues & Volume, By Blood disorders, 2021-2031F |
6.2.6 Ireland Parenteral Drugs Market Revenues & Volume, By Hormonal Disorders, 2021-2031F |
6.2.7 Ireland Parenteral Drugs Market Revenues & Volume, By Musculoskeletal Disorders, 2021-2031F |
6.2.8 Ireland Parenteral Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021-2031F |
6.2.9 Ireland Parenteral Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021-2031F |
6.3 Ireland Parenteral Drugs Market, By Molecule Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Parenteral Drugs Market Revenues & Volume, By Small Molecules, 2021-2031F |
6.3.3 Ireland Parenteral Drugs Market Revenues & Volume, By Large Molecules, 2021-2031F |
6.4 Ireland Parenteral Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Ireland Parenteral Drugs Market Revenues & Volume, By Intravenous (IV), 2021-2031F |
6.4.3 Ireland Parenteral Drugs Market Revenues & Volume, By Intramuscular (IM), 2021-2031F |
6.4.4 Ireland Parenteral Drugs Market Revenues & Volume, By Subcutaneous (SC), 2021-2031F |
6.5 Ireland Parenteral Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Parenteral Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.5.3 Ireland Parenteral Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.5.4 Ireland Parenteral Drugs Market Revenues & Volume, By Drug Stores, 2021-2031F |
6.5.5 Ireland Parenteral Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Ireland Parenteral Drugs Market Import-Export Trade Statistics |
7.1 Ireland Parenteral Drugs Market Export to Major Countries |
7.2 Ireland Parenteral Drugs Market Imports from Major Countries |
8 Ireland Parenteral Drugs Market Key Performance Indicators |
8.1 Number of clinical trials involving parenteral drugs in Ireland |
8.2 Adoption rate of new drug delivery technologies in parenteral drug administration |
8.3 Investment in research and development of parenteral drug formulations |
8.4 Rate of hospital admissions requiring parenteral drug therapy |
8.5 Number of healthcare providers trained in proper administration of parenteral drugs |
9 Ireland Parenteral Drugs Market - Opportunity Assessment |
9.1 Ireland Parenteral Drugs Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Ireland Parenteral Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Parenteral Drugs Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.4 Ireland Parenteral Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Ireland Parenteral Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Parenteral Drugs Market - Competitive Landscape |
10.1 Ireland Parenteral Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ireland Parenteral Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here